| Lastest Insider Transactions Of Cue Biopharma, Inc. ( CUE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CUE | Cue Biopharma, Inc. | Ray Sumita | Chief Legal Compliance Officer | 2026-08-13 | Sell | 8,829 | 30.09 | 265,628 | 2026-08-17 18:22:36 |
| CUE | Cue Biopharma, Inc. | Ray Sumita | Chief Legal Compliance Officer | 2026-08-13 | Option Exercise | 18,196 | 0.00 | 0 | 2026-08-17 18:22:36 |
| CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Officer | 2026-08-13 | Sell | 5,628 | 30.09 | 169,324 | 2026-08-17 18:19:56 |
| CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Officer | 2026-08-13 | Option Exercise | 13,647 | 0.00 | 0 | 2026-08-17 18:19:56 |
| CUE | Cue Biopharma, Inc. | Lin Shao-Lee | Chief Executive Officer | 2026-08-12 | Sell | 58,258 | 27.58 | 1,606,562 | 2026-08-14 20:46:04 |
| CUE | Cue Biopharma, Inc. | Lin Shao-Lee | Chief Executive Officer | 2026-08-12 | Option Exercise | 109,179 | 0.00 | 0 | 2026-08-14 20:46:04 |
| CUE | Cue Biopharma, Inc. | Sarraf Pasha | Directior | 2025-12-30 | Buy | 323,857 | 0.31 | 99,747 | 2026-01-02 16:00:03 |
| CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 2024-12-16 | Buy | 30,000 | 1.03 | 30,900 | 2024-12-18 16:00:04 |
| CUE | Cue Biopharma, Inc. | Suri Anish | PRESIDENT AND CSO | 2023-08-25 | Buy | 4,000 | 2.76 | 11,040 | 2023-08-29 16:08:25 |
| CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 2023-08-14 | Buy | 3,000 | 2.86 | 8,580 | 2023-08-16 16:07:47 |
| CUE | Cue Biopharma, Inc. | Kiener Peter A | Directior | 2023-03-23 | Sell | 9,325 | 3.28 | 30,586 | 2023-03-27 16:05:02 |
| CUE | Cue Biopharma, Inc. | Kiener Peter A | Directior | 2023-03-23 | Option Exercise | 9,682 | 2.86 | 27,691 | 2023-03-27 16:05:02 |
